These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22666427)

  • 1. Modelling the genetic risk in age-related macular degeneration.
    Grassmann F; Fritsche LG; Keilhauer CN; Heid IM; Weber BH
    PLoS One; 2012; 7(5):e37979. PubMed ID: 22666427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Risk, Lifestyle, and Age-Related Macular Degeneration in Europe: The EYE-RISK Consortium.
    Colijn JM; Meester-Smoor M; Verzijden T; de Breuk A; Silva R; Merle BMJ; Cougnard-Grégoire A; Hoyng CB; Fauser S; Coolen A; Creuzot-Garcher C; Hense HW; Ueffing M; Delcourt C; den Hollander AI; Klaver CCW;
    Ophthalmology; 2021 Jul; 128(7):1039-1049. PubMed ID: 33253757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic risk models in age-related macular degeneration.
    Grassmann F; Heid IM; Weber BH
    Adv Exp Med Biol; 2014; 801():291-300. PubMed ID: 24664710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic pleiotropy between age-related macular degeneration and 16 complex diseases and traits.
    Grassmann F; Kiel C; Zimmermann ME; Gorski M; Grassmann V; Stark K; ; Heid IM; Weber BH
    Genome Med; 2017 Mar; 9(1):29. PubMed ID: 28347358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole exome sequencing of extreme age-related macular degeneration phenotypes.
    Sardell RJ; Bailey JN; Courtenay MD; Whitehead P; Laux RA; Adams LD; Fortun JA; Brantley MA; Kovach JL; Schwartz SG; Agarwal A; Scott WK; Haines JL; Pericak-Vance MA
    Mol Vis; 2016; 22():1062-76. PubMed ID: 27625572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Performance of an Updated Polygenic Risk Score for Age-Related Macular Degeneration.
    Yu C; Robman L; He W; Woods RL; Phuong Thao LT; Wolfe R; Phung J; Makeyeva GA; Hodgson LAB; McNeil JJ; Guymer RH; MacGregor S; Lacaze P
    Ophthalmology; 2024 Aug; 131(8):880-891. PubMed ID: 38307466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-Related Macular Degeneration and Extramacular Drusen: Genetic Associations in the Coimbra Eye Study.
    Farinha C; Barreto P; Coimbra R; Machado MB; Figueiredo I; Cachulo ML; Cunha-Vaz J; Silva R
    Invest Ophthalmol Vis Sci; 2024 May; 65(5):35. PubMed ID: 38776116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare Genetic Variants in Complement Factor I Lead to Low FI Plasma Levels Resulting in Increased Risk of Age-Related Macular Degeneration.
    Hallam TM; Marchbank KJ; Harris CL; Osmond C; Shuttleworth VG; Griffiths H; Cree AJ; Kavanagh D; Lotery AJ
    Invest Ophthalmol Vis Sci; 2020 Jun; 61(6):18. PubMed ID: 32516404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of Unilateral and Bilateral Age-Related Macular Degeneration Severity Stages.
    Schick T; Altay L; Viehweger E; Hoyng CB; den Hollander AI; Felsch M; Fauser S
    PLoS One; 2016; 11(6):e0156778. PubMed ID: 27257685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unveiling Statins and Genetics in Age-Related Macular Degeneration: The Coimbra Eye Study-Report 9.
    Barreto P; Farinha C; Coimbra R; Cachulo ML; Melo JB; Lechanteur Y; Hoyng CB; Cunha-Vaz J; Silva R
    Invest Ophthalmol Vis Sci; 2024 Jun; 65(6):38. PubMed ID: 38935028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Prediction for Progression of Macular Degeneration: 10 Common and Rare Genetic Variants, Demographic, Environmental, and Macular Covariates.
    Seddon JM; Silver RE; Kwong M; Rosner B
    Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2192-202. PubMed ID: 25655794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ARMS2 increases the risk of early and late age-related macular degeneration in the European Eye Study.
    Chakravarthy U; McKay GJ; de Jong PT; Rahu M; Seland J; Soubrane G; Tomazzoli L; Topouzis F; Vingerling JR; Vioque J; Young IS; Sofat R; Hingorani AD; Fletcher AE
    Ophthalmology; 2013 Feb; 120(2):342-8. PubMed ID: 23098369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Risk Score Analysis Supports a Joint View of Two Classification Systems for Age-Related Macular Degeneration.
    Herold JM; Zimmermann ME; Gorski M; Günther F; Weber BHF; Helbig H; Stark KJ; Heid IM; Brandl C
    Invest Ophthalmol Vis Sci; 2023 Sep; 64(12):31. PubMed ID: 37721739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Joint Analysis of Nuclear and Mitochondrial Variants in Age-Related Macular Degeneration Identifies Novel Loci TRPM1 and ABHD2/RLBP1.
    Persad PJ; Heid IM; Weeks DE; Baird PN; de Jong EK; Haines JL; Pericak-Vance MA; Scott WK;
    Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):4027-4038. PubMed ID: 28813576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neovascular age-related macular degeneration risk based on CFH, LOC387715/HTRA1, and smoking.
    Hughes AE; Orr N; Patterson C; Esfandiary H; Hogg R; McConnell V; Silvestri G; Chakravarthy U
    PLoS Med; 2007 Dec; 4(12):e355. PubMed ID: 18162041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the contribution of CFH and chromosome 10q26 AMD susceptibility loci in a Russian population isolate.
    Fisher SA; Rivera A; Fritsche LG; Babadjanova G; Petrov S; Weber BH
    Br J Ophthalmol; 2007 May; 91(5):576-8. PubMed ID: 17050575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Contribution of Genetic Architecture to the 10-Year Incidence of Age-Related Macular Degeneration in the Fellow Eye.
    Miyake M; Yamashiro K; Tamura H; Kumagai K; Saito M; Sugahara-Kuroda M; Yoshikawa M; Oishi M; Akagi-Kurashige Y; Nakata I; Nakanishi H; Gotoh N; Oishi A; Matsuda F; Yamada R; Khor CC; Kurimoto Y; Sekiryu T; Tsujikawa A; Yoshimura N
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5353-61. PubMed ID: 26275133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single nucleotide polymorphisms of the tenomodulin gene (TNMD) in age-related macular degeneration.
    Tolppanen AM; Nevalainen T; Kolehmainen M; Seitsonen S; Immonen I; Uusitupa M; Kaarniranta K; Pulkkinen L
    Mol Vis; 2009; 15():762-70. PubMed ID: 19381347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic risk score has added value over initial clinical grading stage in predicting disease progression in age-related macular degeneration.
    Heesterbeek TJ; de Jong EK; Acar IE; Groenewoud JMM; Liefers B; Sánchez CI; Peto T; Hoyng CB; Pauleikhoff D; Hense HW; den Hollander AI
    Sci Rep; 2019 Apr; 9(1):6611. PubMed ID: 31036867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical validation of a genetic model to estimate the risk of developing choroidal neovascular age-related macular degeneration.
    Hageman GS; Gehrs K; Lejnine S; Bansal AT; Deangelis MM; Guymer RH; Baird PN; Allikmets R; Deciu C; Oeth P; Perlee LT
    Hum Genomics; 2011 Jul; 5(5):420-40. PubMed ID: 21807600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.